This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Barzu, S. Articles by Phalipon, A. Search for Related Content PubMed PubMed Citation Articles by Barzu, S. Articles by Phalipon, A.

 Previous Article  |  Next Article 

Infect. Immun., 04 1996, 1190-1196, Vol 64, No. 4
Copyright © 1996, American Society for Microbiology

Induction of a local anti-IpaC antibody response in mice by use of a Shigella flexneri 2a vaccine candidate: implications for use of IpaC as a protein carrier

S Barzu, A Fontaine, P Sansonetti and A Phalipon
Unite de Pathogenie Microbienne Moleculaire, U389 Institut National de la Sante et de la Recherche Medicale, Institut Pasteur, Paris, France.

The capacity of Shigella flexneri to act as a delivery system for stimulation of local immunity was investigated by use of an S. Flexneri 2a vaccine candidate (SC602). This vaccine strain was constructed by deletion of virulence genes responsible for dissemination (icsA) and survival (iuc:iut) of bacteria within the colonic mucosa. Among the most immunogenic S. flexneri 2a proteins inducing a local immunoglobulin A antibody response, the IpaC invasion was selected as a potential protein carrier. Overexpression of IpaC from a plasmid in trans within SC602 (SC602/pIpaC) was shown to be required for the induction of optimal anti-IpaC antibody response in the murine pulmonary infection model. A weak anti-IpaC antibody response was obtained after intranasal inoculations with SC602/pIpaC live bacteria. This response was enhanced by combining systemic priming with SC602/pIpaC killed bacteria and local boosting with SC602/pIpaC live bacteria. These results suggest that naive B cells primed systemically could account for local antibody production. This immunization protocol will allow further evaluation of the immunogenicity of IpaC hybrid proteins expresses in SC602.

This article has been cited by other articles:

• Rallabhandi, P., Awomoyi, A., Thomas, K. E., Phalipon, A., Fujimoto, Y., Fukase, K., Kusumoto, S., Qureshi, N., Sztein, M. B., Vogel, S. N. (2008). Differential Activation of Human TLR4 by Escherichia coli and Shigella flexneri 2a Lipopolysaccharide: Combined Effects of Lipid A Acylation State and TLR4 Polymorphisms on Signaling. J. Immunol. 180: 1139-1147 [Abstract] [Full Text]  
• Shim, D.-H., Suzuki, T., Chang, S.-Y., Park, S.-M., Sansonetti, P. J., Sasakawa, C., Kweon, M.-N. (2007). New Animal Model of Shigellosis in the Guinea Pig: Its Usefulness for Protective Efficacy Studies. J. Immunol. 178: 2476-2482 [Abstract] [Full Text]  
• Ranallo, R. T., Fonseka, C. P., Cassels, F., Srinivasan, J., Venkatesan, M. M. (2005). Construction and Characterization of Bivalent Shigella flexneri 2a Vaccine Strains SC608(pCFAI) and SC608(pCFAI/LTB) That Express Antigens from Enterotoxigenic Escherichia coli. Infect. Immun. 73: 258-267 [Abstract] [Full Text]  
• Coster, T. S., Hoge, C. W., VanDeVerg, L. L., Hartman, A. B., Oaks, E. V., Venkatesan, M. M., Cohen, D., Robin, G., Fontaine-Thompson, A., Sansonetti, P. J., Hale, T. L. (1999). Vaccination against Shigellosis with Attenuated Shigella flexneri 2a Strain SC602. Infect. Immun. 67: 3437-3443 [Abstract] [Full Text]  
• Berlutti, F., Casalino, M., Zagaglia, C., Fradiani, P. A., Visca, P., Nicoletti, M. (1998). Expression of the Virulence Plasmid-Carried Apyrase Gene (apy) of Enteroinvasive Escherichia coli and Shigella flexneri Is under the Control of H-NS and the VirF and VirB Regulatory Cascade. Infect. Immun. 66: 4957-4964 [Abstract] [Full Text]  
• Barzu, S., Arondel, J., Guillot, S., Sansonetti, P. J., Phalipon, A. (1998). Immunogenicity of IpaC-Hybrid Proteins Expressed in the Shigella flexneri 2a Vaccine Candidate SC602. Infect. Immun. 66: 77-82 [Abstract] [Full Text]